Entecavir versus lamivudine for the treatment of chronic hepatitis B: a systematic review.
Liang Jian, Tang Yan-Fang, Wu Fa-Sheng, +1 more·Die Pharmazie
The aim of this study was to systematically review the efficacy and safety of entecavir versus lamivudine for the treatment of chronic hepatitis B (CHB). A computerized search of The Cochrane Library (CENTRAL, Issue 5, 2011), MEDLINE (PubMed, 1978-June 2011), EMbase (1974-June 2011) and CNKI (1978-June 2011) databases…